← Back to Search

Behavioural Intervention

Virtual Reality for Chest Pain

N/A
Recruiting
Led By Andree Koop, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Symptoms of non-cardiac chest pain (recurrent anginal-like or atypical chest pain)
Be older than 18 years old
Must not have
Symptoms of vertigo or dizziness that would limit tolerability of the VR headset
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 2
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if virtual reality can help improve symptoms in people with non-cardiac chest pain."

Who is the study for?
This trial is for people with non-cardiac chest pain who've had tests to rule out severe esophagus issues and heart problems. They shouldn't have started new acid reflux medication recently, have major illnesses, substance abuse issues, or vertigo that would make using VR hard.
What is being tested?
The study is testing if virtual reality can help ease chest pain that's not related to the heart. Participants will use a VR headset as part of the treatment to see if it improves their symptoms.
What are the potential side effects?
Since this trial involves virtual reality, side effects may include temporary discomfort like headaches or eye strain from the headset, and possibly nausea or dizziness especially in those prone to motion sickness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience chest pain that is not related to heart issues.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I experience vertigo or dizziness that makes using a VR headset hard.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measure changes in GERD quality of life using the GERD-HRQL questionnaire
Measure changes in GERD symptoms using the GERDQ questionnare
Measure changes in GI related patient assessment of quality of life using PAGI-QOL
+2 more
Secondary study objectives
Measure changes in anxiety and depression using the HADs scale
Measure changes in resilience using the brief resilience scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: VR ArmExperimental Treatment1 Intervention
Viritual Reality therapy arm. All patients will receive virtual reality therapy.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,326 Previous Clinical Trials
3,059,484 Total Patients Enrolled
5 Trials studying Chest Pain
2,422 Patients Enrolled for Chest Pain
Andree Koop, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
80 Total Patients Enrolled
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top